A similar scenario has been previously reported in T-cell tumors and B-cell non-Hodgkin lymphoma, where both phospho-FADD positivity and signal intensity exhibited a high variation [28, 29]. The gene discussed is FADD; the disease is B-cell non-Hodgkin lymphoma.